Progressive pseudorheumatoid dysplasia

From WikiMD's Wellnesspedia

Alternate names[edit | edit source]

Spondyloepiphyseal dysplasia tarda-progressive arthropathy syndrome; Progressive pseudorheumatoid arthropathy of childhood; PPAC; Spondyloepiphyseal dysplasia tarda - progressive arthropathy; PPD; SEDT-PA; Arthropathy, progressive pseudorheumatoid, of childhood; Spondyloepiphyseal dysplasia tarda with progressive arthropathy; Progressive pseudorheumatoid chondrodysplasia

Definition[edit | edit source]

Progressive pseudorheumatoid disyplasia (PPD) is a disorder of bone and cartilage that affects many joints. It manifests between the age of 3 and 6 years with joint pain and progressive joint stiffness.

Summary[edit | edit source]

  • This condition is characterized by breakdown (degeneration) of the cartilage between bones (articular cartilage).
  • This cartilage covers and protects the ends of bones, and its degeneration leads to pain and stiffness in the joints and other features of PPRD.
  • PPRD is often mistaken for another joint disorder that affects young people called juvenile rheumatoid arthritis.
  • However, the joint problems in juvenile rheumatoid arthritis are associated with inflammation, while those in PPRD are not.

Epidemiology[edit | edit source]

  • PPRD has been estimated to occur in approximately 1 per million people in the United Kingdom.
  • The condition is thought to be more common in Turkey and the Middle East, although its prevalence in these regions is unknown.
  • The condition in all regions is likely underdiagnosed because it is often misdiagnosed as juvenile rheumatoid arthritis.

Cause[edit | edit source]

  • PPRD is caused by mutations in the CCN6 gene.
  • The function of the protein produced from this gene is not well understood, although it is thought to play a role in bone growth and cartilage maintenance.
  • The CCN6 protein is made in cells called chondrocytes, which produce and maintain cartilage.
  • This protein is associated with the production of certain proteins that make up cartilage, but its role in their production is unclear.
  • CCN6 may also help control signaling pathways involved in the development of cartilage and bone and may help regulate the breakdown of cartilage components.

Gene mutatios[edit | edit source]

  • CCN6 gene mutations lead to an altered protein that may not function.
  • Loss of CCN6 protein function likely disrupts normal cartilage maintenance and bone growth, leading to the cartilage degeneration and joint problems that occur in PPRD.

Inheritance[edit | edit source]

Autosomal recessive inheritance, a 25% chance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Onset[edit | edit source]

PPRD usually begins in childhood, between ages 3 and 8.

Signs and symptoms[edit | edit source]

  • The first indications are usually an abnormal walking pattern, weakness and fatigue when active, and stiffness in the joints in the fingers and in the knees.
  • Other signs and symptoms that develop over time include permanently bent fingers (camptodactyly), enlarged finger and knee joints (often mistaken as swelling), and a reduced amount of space between the bones at the hip and knee joints.
  • Hip pain is a common problem by adolescence.
  • Affected individuals have flattened bones in the spine (platyspondyly) that are abnormally shaped (beaked), which leads to an abnormal front-to-back curvature of the spine (kyphosis) and a short torso.
  • At birth, people with PPRD are of normal length, but by adulthood, they are usually shorter than their peers.
  • Affected adults also have abnormal deposits of calcium around the elbow, knee, and hip joints and limited movement in all joints, including those of the spine.

Clinical presentation[edit | edit source]

For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed.

80%-99% of people have these symptoms

30%-79% of people have these symptoms

Diagnosis[edit | edit source]

PPD should be suspected in individuals with the following clinical, laboratory, and radiologic features.[1][1].


Clinical features

  • Healthy at birth
  • Onset of arthropathy early in childhood, usually between ages three and six years
  • Enlargement of interphalangeal joints of hands (Figure 1)
  • Progressive restricted mobility of all joints
  • Gait abnormalities
  • Genu valgum / genu varum
  • Progressive hip disease (commonly coxa vara at the late stage)
  • Articular pain
  • Motor weakness and fatigability
  • Spine involvement in late childhood and adolescence with thoracolumbar kyphoscoliosis that leads to short trunk
  • Adult height below the third centile
  • Absence of signs of inflammation

Laboratory features include normal erythrocyte sedimentation rate and C-reactive protein levels.

Radiologic features include spondyloepiphyseal dysplasia, generalized arthropathy, distinctive joint deformity of the hands (superficially resembling that of juvenile idiopathic arthritis), and diffuse osteoporosis at the late stage.

The diagnosis of PPD can be established in a proband with characteristic radiographic features and/or biallelic pathogenic variants in CCN6 (formerly WISP3) identified on molecular genetic testing.

Treatment[edit | edit source]


References[edit | edit source]

  1. Bhavani GSL, Shah H, Shukla A, et al. Progressive Pseudorheumatoid Dysplasia. 2015 Nov 25 [Updated 2020 Dec 23]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK327267/
  2. Bhavani GSL, Shah H, Shukla A, et al. Progressive Pseudorheumatoid Dysplasia. 2015 Nov 25 [Updated 2020 Dec 23]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK327267/

NIH genetic and rare disease info[edit source]

Progressive pseudorheumatoid dysplasia is a rare disease.


Wikimd.png
This article is a stub.

Help WikiMD grow by registering to expand it.
Editing is available only to registered and verified users.
About WikiMD: A comprehensive, free health & wellness encyclopedia.

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Deepika vegiraju